Frederick G. Hayden, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Full Professor
Years: 1990-2015

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Professor Emeritus
Years: 2015-Present

None Reported

Interferon beta-1b and lopinavir–ritonavir for Middle East Respiratory Syndrome.
NEJM
Date: 05 2020
doi:10.1056/NEJMoa2015294

Baloxavir marboxil for prophylaxis against influenza in household contacts
NEJM
Date: 06 2020
doi:10.1056/NEJMoa1915341

Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment.
Clinical Infectious Diseases
Date: 07 2021
doi.org/10.1093/cid/ciab625

Heterogeneity of Treatment Effect of Interferon-β1b and Lopinavir–ritonavir in MERS by Cytokine Levels
Science Reports
Volume: 12
Date: 10 2022
doi.org/10.1038/s41598-022-22742-8

Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-blind, Placebo-controlled Trials
J Infectious Diseases
Volume: 226
Date: 11 2022
doi.org/10.1093/infdis/jiac135

Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala
Emerg Infect Dis
28(Suppl 1)
Date: 12 2022
stacks.cdc.gov/view/cdc/123282

Oral Favipiravir Exposure and Pharmacodynamic Effects in Adult Outpatients With Acute Influenza
J Infectious Diseases
Date: 09 2023
https://doi.org/10.1093/infdis/jiad409